Loblaw Companies Limited · TSX:L
Loblaw Companies — Q4 2015 Earnings Presentation
6 slides from Loblaw Companies's earnings presentation, Feb 25, 2016
Slide 1: Q4 2015 Supplementary Slides
Q4 2015 Supplementary Slides February 25, 2015 1
Slide 2: Forward-looking Statements
Forward-looking Statements This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated – Q4 2015
Key Financial Metrics – Consolidated – Q4 2015 Consolidated Revenue $10,865 M, +2.3% (excluding the 53rd week in 2014) Consolidated Adjusted EBITDA $881 M, +0.2% (excluding the 53rd week in 2014) Adjusted Basic Net Earnings Per $0.88, +6.0% (excluding the 53rd week in 2014) Common Share Net Efficien
Slide 4: Key Financial Metrics – Retail Segment – Q4 2015
Key Financial Metrics – Retail Segment – Q4 2015 Total Retail Revenue $10,606 M, +2.2% (excluding the 53rd week in 2014) Retail Revenue – Food Retail (Loblaw) $7,631 M, +1.3% (excluding the 53rd week in 2014) Retail Revenue – Drug Retail (Shoppers Drug Mart) $2,975 M, +4.8% (excluding the 53rd week
Slide 5: Key Operational Metrics – Food Retail (Loblaw) – Q4 2015
Key Operational Metrics – Food Retail (Loblaw) – Q4 2015 Food Retail Same-Store Sales +3.1% (ex Gas Bar (+50bps) and the negative impact of a change in the distribution model by a tobacco supplier (+20bps); Growth including these items food retail comp SSS was +2.4%) Basket Size Increased Traffic Po
Slide 6: Key Operational Metrics – Q4 2015
Key Operational Metrics – Q4 2015 Drug Retail (Shoppers Drug Mart) Pharmacy Sales $1,315 M Pharmacy SSS +4.2% # Rx Dispensed (Rx Count) -4.7% (+3.2% on same store sales basis) Average Rx Value +0.9% Generic Penetration 63.7% (vs. 64.1% Q4 2014) Front Store Sales $1,660 M Front Store SSS +5.7% Loyalt